Key Takeaways
- • Tandem Health closed a €40–50 million Series A funding round led by Kinnevik, with participation from Northzone, Amino Collective, and Visionaries Club, positioning the Swedish healthtech startup as Europe's leading AI medical assistant platform.
- • The company has achieved significant scale with tens of thousands of clinicians across Europe using its AI assistant for clinical note generation, and over 200,000 NHS professionals in the UK now have access through a partnership with Accurx, representing one of the largest healthcare AI rollouts globally.
- • The new capital will fund expansion of Tandem's platform beyond clinical documentation to build a complete AI-native operating system covering clinical coding, care coordination, and decision support at the point of care.
- • Founded in 2023, Tandem Health is focused on reducing administrative burden on healthcare providers by automating documentation workflows, enabling clinicians to spend more time on patient care rather than data entry.
- • Spain has been identified as a priority market for growth, with the company targeting broader European expansion as part of its Series A strategy.
Summary
Tandem Health, a Swedish healthtech company founded in 2023, has secured €40–50 million in Series A funding to accelerate development of its AI-native clinical workflow platform. The round was led by Kinnevik with support from existing and new investors including Northzone, Amino Collective, and Visionaries Club. The capital injection reflects strong institutional confidence in the company's market positioning and technology approach in the rapidly expanding European healthcare AI sector.
The company has achieved substantial market penetration across Europe, with tens of thousands of clinicians now actively using Tandem's AI assistant for real-time clinical note generation. Most notably, a partnership with UK healthcare communications platform Accurx has enabled over 200,000 NHS professionals to access Tandem's technology, representing one of the largest healthcare AI rollouts anywhere globally. This adoption demonstrates both clinical utility and regulatory acceptance of AI-assisted documentation within established healthcare systems.
Tandem's core offering addresses a structural inefficiency in healthcare delivery: the administrative burden that diverts clinician attention from patient interaction. The platform generates accurate, compliant clinical records through voice-to-text AI as providers interact with patients, eliminating post-consultation typing and enabling notes to be ready before patients leave the room. The company frames this as restoration of clinical presence and patient trust rather than pure automation for efficiency gains.
With Series A proceeds, Tandem is expanding beyond documentation to build a comprehensive AI-native operating system spanning the full clinical workflow. This includes clinical coding capture, care coordination tools, and point-of-care clinical decision support. Spain has been identified as a priority growth market, signaling geographic diversification across Southern Europe beyond current operational strongholds. The funding supports both platform enhancement and geographic expansion to capture market share in Europe's fragmented healthcare IT landscape.
The company has achieved substantial market penetration across Europe, with tens of thousands of clinicians now actively using Tandem's AI assistant for real-time clinical note generation. Most notably, a partnership with UK healthcare communications platform Accurx has enabled over 200,000 NHS professionals to access Tandem's technology, representing one of the largest healthcare AI rollouts anywhere globally. This adoption demonstrates both clinical utility and regulatory acceptance of AI-assisted documentation within established healthcare systems.
Tandem's core offering addresses a structural inefficiency in healthcare delivery: the administrative burden that diverts clinician attention from patient interaction. The platform generates accurate, compliant clinical records through voice-to-text AI as providers interact with patients, eliminating post-consultation typing and enabling notes to be ready before patients leave the room. The company frames this as restoration of clinical presence and patient trust rather than pure automation for efficiency gains.
With Series A proceeds, Tandem is expanding beyond documentation to build a comprehensive AI-native operating system spanning the full clinical workflow. This includes clinical coding capture, care coordination tools, and point-of-care clinical decision support. Spain has been identified as a priority growth market, signaling geographic diversification across Southern Europe beyond current operational strongholds. The funding supports both platform enhancement and geographic expansion to capture market share in Europe's fragmented healthcare IT landscape.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.